Li Ran Xu
Director/Board Member at Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Heping Wang | M | 71 |
Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.
 Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd. engages in the research, development, production, and marketing of biotechnology drugs. The company was founded on December 18, 1992 and is headquartered in Shenzhen, China. | - |
| Xun He | M | 60 |
Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.
Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd. engages in the research, development, production, and marketing of biotechnology drugs. The company was founded on December 18, 1992 and is headquartered in Shenzhen, China. | 8 years |
| Qi Long Zhang | M | - |
Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.
Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd. engages in the research, development, production, and marketing of biotechnology drugs. The company was founded on December 18, 1992 and is headquartered in Shenzhen, China. | - |
| Mei Wang | F | - |
Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.
Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd. engages in the research, development, production, and marketing of biotechnology drugs. The company was founded on December 18, 1992 and is headquartered in Shenzhen, China. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 4 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Li Ran Xu
- Personal Network
